Trinity Biotech (NASDAQ:TRIB) Stock Rating Lowered by StockNews.com

Trinity Biotech (NASDAQ:TRIB) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Thursday.

Trinity Biotech Price Performance

Shares of NASDAQ TRIB opened at $0.69 on Thursday. The company has a market capitalization of $12.48 million, a price-to-earnings ratio of -0.31 and a beta of 1.20. The business has a 50-day moving average of $0.83 and a two-hundred day moving average of $1.24. Trinity Biotech has a 1 year low of $0.63 and a 1 year high of $3.55.

Institutional Trading of Trinity Biotech

An institutional investor recently raised its position in Trinity Biotech stock. Hunter Associates Investment Management LLC increased its position in Trinity Biotech plc (NASDAQ:TRIB) by 5.2% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 378,590 shares of the company’s stock after purchasing an additional 18,780 shares during the period. Hunter Associates Investment Management LLC’s holdings in Trinity Biotech were worth $334,000 at the end of the most recent quarter. Institutional investors and hedge funds own 78.97% of the company’s stock.

Trinity Biotech Company Profile

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.